R Interferon beta

Related by string. * Rs . red . Rd . R. . ring : MS RD . Rs #.# [005] . Bill Frist R Tenn . R Ind . RED FLAG WARNING WHICH / Interferons . interferons . interferon : Topical Interferon Alpha 2b . PEG Interferon lambda . interferon beta 1a . interferon beta 1a infertility . pegylated interferon ribavirin / BETA . betas . Betas . beta. : Pi Beta Phi . Beta Theta Pi . Beta Sigma Phi . Zeta Phi Beta Sorority * *

Related by context. Frequent words. (Click for all words.) 64 Initiate Phase 62 Pivotal Phase 61 Initiates Phase 59 RITUXAN 58 MYoung Texas 57 BRoberts Baltimore 57 elotuzumab 57 LGonzalez Arizona 56 ASoriano Texas 56 metastatic hormone refractory 56 Pivotal Phase III 56 Ixempra 55 multicenter Phase 55 MGiles Atlanta 55 Freel Cincinnati 55 JWilson Pittsburgh 55 Noncritical violations found 55 g trans fats 54 MOrdonez Detroit 54 HaRamirez Florida 54 R sorafenib tablets 54 BioMarin Genzyme LLC 53 Consensus +#.# 53 Gemzar ® 53 AHill Toronto 53 relapsed refractory multiple myeloma 53 TRC# 53 registrational trial 53 PrWilson Colorado 53 Cloretazine R VNP#M 53 ONTAK 52 VWells Toronto 52 placebo controlled Phase 52 MiCabrera Florida 52 Xalatan 52 AJones Atlanta 52 Don Null 51 BPhillips Cincinnati 51 neurogenic orthostatic hypotension 51 ZALBIN 51 [014] 51 INTEGRILIN 51 AZASITE 51 Eligard R 51 Phase Ib clinical 51 PLAVIX R 51 mso tstyle colband size 50 mso tstyle rowband size 50 aflibercept 50 AVINZA 50 TPIAO 50 MRamirez Boston 50 MiCabrera Detroit 50 Interest Income Expense 50 Actimmune R 50 Guides FY# Quick Facts 50 3Q FY# 50 Phase 1b 50 MAXY 49 NET REVENUES 49 confirmatory Phase III 49 AEterna 49 DOrtiz Boston 49 Angio Seal TM 49 Belinostat 49 phase IIb 49 RESEARCH AND DEVELOPMENT 49 THE PUEBLO CHIEFTAIN 49 bd div story 49 TRISENOX 49 ridaforolimus 49 NV Organon 48 INCOME LOSS BEFORE INCOME 48 6 Cyl 48 Phase IIb trials 48 VANTAS 48 InKine 48 Solzira 48 Phase 1a 48 8 Cyl 48 custirsen 48 INCOME LOSS FROM CONTINUING 48 Engerix B 47 Beautiful QWERTY keyboard 47 Fully diluted EPS 47 Phase 2a trial 47 Interest Expense Net 47 Restructuring Charges 47 OLEPTRO TM 47 Phase Ia 47 Esprit Pharma 47 Phase 2b study 47 EndoTAG TM -1 47 totaled SEK 47 By Darrell Laurant 47 contracting activity F# 47 By JEFF TUCKER 47 ADVENTRX Pharmaceuticals 47 BY OWNER 47 Pro forma EBITDA 47 marketable securities totaled

Back to home page